Rachman Jonathan 4
4 · OSI PHARMACEUTICALS INC · Filed Dec 15, 2009
Insider Transaction Report
Form 4
Rachman Jonathan
Sr VP, Diabetes/Obesity R&D
Transactions
- Tax Payment
Common Stock
2009-12-12$34.75/sh−452$15,707→ 8,508 total - Tax Payment
Common Stock
2009-12-13$34.75/sh−304$10,564→ 8,204 total
Footnotes (1)
- [F1]Reflects the withholding of shares by the Company to satisfy the tax liability upon the vesting of Restricted Stock Units.